Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Allergopharma

Allergopharma
M&A STATUS
Corporate LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of allergy treatment products. The company operates in the field of allergen immunotherapy and offers high-dose, hypoallergenic, standardized products for the treatment of allergic diseases such as pollen and mite allergies.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • Hermann-Körner-Street 52
  • 21465 Reinbek
  • Germany

+49 040 000000

Allergopharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Allergopharma‘s full profile, request access.

Request full access to PitchBook

Allergopharma Executive Team (2)

Name Title Board
Seat
Contact
Info
Philipp Maerz Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »